Creadev led a €15m Series B round in Damae Medical.

Creadev, an evergreen investment company, led a €15m Series B round in Damae Medical, a medical company, with participation from Kurma Partners and BNP Paribas Developpement. “Damae offers an essential solution to improve the management of skin cancers and accelerate dermatology research with new data. We are impressed by the company’s maturity in both optics and AI and proud to support such a talented team capable of establishing new standards in close collaboration with physicians,” Marc Chipot, Creadev Investment Director.